The WACC of Aeglea Bio Therapeutics Inc (AGLE) is 8.1%.
| Range | Selected | |
| Cost of equity | 9.90% - 14.90% | 12.40% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 6.8% - 9.3% | 8.1% |
| Category | Low | High |
| Long-term bond rate | 4.2% | 4.7% |
| Equity market risk premium | 5.0% | 6.0% |
| Adjusted beta | 1.15 | 1.63 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 9.90% | 14.90% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 6.8% | 9.3% |
| Selected WACC | 8.1% | |